Mitchell Kronenberg

Invivoscribe, Inc. has been a leader in precision diagnostics for over 25 years. Invivoscribe is based in San Diego, CA and was founded in 1955 by Jeffrey Edward Miller, who has been the CEO since then. The company develops and sell standardized reagents, tests, and bioinformatics tools to over 700 customers in 160 countries. The company also works with pharmaceutical companies to accelerate approvals of new drugs and treatments by supporting international clinical trials, developing, commercializing companion diagnostics, and providing expertise in both regulatory and laboratory services.